2015
DOI: 10.1093/cvr/cvv042
|View full text |Cite|
|
Sign up to set email alerts
|

Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study

Abstract: Rare variants in the screened QRS-associated genes (including SCN10A) are not responsible for a significant proportion of SCN5A mutation negative BrS. The common SNP SCN10A V1073 was strongly associated with BrS and demonstrated loss of NaV1.8 function, as did rare variants in isolated patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
96
6
2

Year Published

2015
2015
2021
2021

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 102 publications
(107 citation statements)
references
References 25 publications
3
96
6
2
Order By: Relevance
“…A recent study has identified 17 SCN10A mutations in 16.7 % of 25 BrS cases and confirmed SCN10A as a major susceptibility gene for BrS [19], which was consistent with other studies [20][21][22]. Nevertheless, the association has not been studied in SUNDS cases.…”
Section: Introductionsupporting
confidence: 82%
See 1 more Smart Citation
“…A recent study has identified 17 SCN10A mutations in 16.7 % of 25 BrS cases and confirmed SCN10A as a major susceptibility gene for BrS [19], which was consistent with other studies [20][21][22]. Nevertheless, the association has not been studied in SUNDS cases.…”
Section: Introductionsupporting
confidence: 82%
“…Single nucleotide polymorphism rs6795970 (V1073A) is located in exon 17 with substitution c.3218T>C. Behr ER et al [22] identified that SCN10A common SNP V1073 was strongly associated with BrS and demonstrated loss of Na v 1.8 function through the gene sequence and voltage-clamp experiments in 156 Caucasian SCN5A mutation-negative BrS patients. Iio et al [41] suggested that the rs6795970 in the SCN10A gene might be associated with cardiac conduction abnormalities in hypertrophic cardiomyopathy (HCM) patients.…”
Section: Discussionmentioning
confidence: 99%
“…91 Interestingly, 2 more recent studies did not reproduce the previous findings and the authors conclude that rare variants in SCN10A are not enriched in patients with BrS. 92,93 The primary role of genetic testing in the BrS is in confirmation of the disorder in the index patient and cascade testing in relatives to distinguish those who need clinical follow-up (for the development of conduction disease or for syncopal episodes) and preventive measures (eg, avoiding specific drugs, prompt management of fever) from those who are both clinically and genetically unaffected. 8,14 One study suggested that patients carrying an SCN5A mutation that leads to a prematurely truncated protein (stop codon or frameshift) were more likely to present with syncope and develop prolonged PR and QRS intervals in comparison with patients harboring missense mutations.…”
Section: Brugada Syndromementioning
confidence: 88%
“…Гомозиготный генотип GG гена SCN10A играет протективную роль в отношении развития идиопатических атриовентрикулярных блокад и блокады правой ножки пучка Гиса. [3][4][5][6][7][8]. Однако имеющиеся результаты по гену SCN10A были получены при исследовании пациентов евро-пейской, азиатской и афроамериканской популяций, среди лиц сибирской популяции данный ген ранее не изучался.…”
Section: новый генетический маркер врожденной патологии проводящей сиunclassified